首页 | 本学科首页   官方微博 | 高级检索  
检索        


Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib)
Institution:1. Translational Pediatrics and Infectious Diseases, Department of Pediatrics, Hospital Clinico Universitario de Santiago de Compostela, c/ A Choupana s.n., 15706 Santiago de Compostela, Spain;2. Sanofi Pasteur MSD, 162 Avenue Jean Jaurès, CS 50712, 69367 Lyon Cedex 07, France;3. Manchester Medical Microbiology Partnership, Public Health England, PO Box 209, Clinical Sciences Building, Manchester Royal Infirmary, Manchester M13 9WZ, UK;1. Vaccinology and Immunology Research Trials Unit, Women''s and Children''s Hospital and Robinson Research Institute and School of Medicine, University of Adelaide, North Adelaide, SA, Australia;2. University of Western Australia School of Paediatrics and Child Health and Vaccine Trials Group, Telethon Kids Institute, Princess Margaret Hospital for Children, Subiaco, WA, Australia;3. Pfizer Vaccine Clinical Research, Maidenhead, UK;4. Pfizer Vaccine Clinical Research and Development, Collegeville, PA, USA;5. Pfizer Vaccine Clinical Research and Development, Pearl River, NY, USA;6. Nazaret Health Center, Valencia, Spain;7. Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago de Compostela and Vaccine Research Unit, Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, Spain;8. Department of Pediatric Infectious Diseases, Wroclaw University of Medicine, Wroclaw, Poland;9. Poznań University of Medical Sciences, Poznań, Poland;1. College of Animal Science, Jilin University, Jilin 130062, China;2. State Key Laboratory of Pathogen & Biosecurity, Beijing Institute of Microbiology & Epidemiology, Beijing 100071, China;3. Liaocheng People’s Hospital, Shandong 252000, China;4. Tangshan Maternal and Child Health Care Hospital, Hebei 063000, China;5. Beijing Ditan Hospital, Capital Medical University, Beijing 100071, China;6. Changchun Hygeia Biotech Co, Ltd, Jilin 130000, China;1. Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea;2. Hallym University College of Medicine, Seoul, Republic of Korea;3. St. Vincent''s Hospital, Catholic University of Korea College of Medicine, Suwon, Gyeonggi-do, Republic of Korea;4. Inha University College of Medicine, Incheon, Republic of Korea;5. Kyungpook National University School of Medicine, Daegu, Republic of Korea;6. Transgovernmental Enterprise for Pandemic Influenza in Korea, Seoul, Republic of Korea;7. Life Science Research Institute, SK Chemicals, Seongnam, Gyeonggi-do, Republic of Korea;1. Department of Pharmacy, College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong 30019, Republic of Korea;2. Viral Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea;3. Department of Pharmacy, College of Pharmacy, Chungbuk National University, 52 Naesudong-ro, Heungdeok-gu, Cheongju, Chungcheongbuk-do 28644, Republic of Korea;4. College of Veterinary Medicine, Gyeongsang National University, 501 Jinjudae-ro, Jinju, Gyeongsangnam-do 52828, Republic of Korea;1. US Medical Affairs, Sanofi Pasteur, Swiftwater, PA, USA;2. Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN, USA;3. Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA;4. Global Medical Affairs, Sanofi Pasteur, Swiftwater, PA, USA;1. Ministry of Health, El Salvador;2. US Centers for Disease Control and Prevention, Atlanta, GA, United States;3. Emory University, United States;4. Pan American Health Organization, El Salvador;5. Consultant for the Pan American Health Organization, United States;6. Pan American Health Organization, Washington, DC, United States
Abstract:
Keywords:DTaP5-IPV-HB-Hib  Primary series  Mixed schedule  Vaccine immune response  Safety profile
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号